(Total Views: 439)
Posted On: 08/26/2019 7:59:14 AM
Post# of 72444
Yes, I noted our superior delivery mechanism. That said, an IV treatment that works is much better than severe OM.
GC4419 received breakthrough designation from the FDA. So it definitely works well. We will need phase 3 data on both drugs to know which works better.
Galera also raised money earlier this year for the phase 3 trials they will conduct. They will very likely succeed and be waiting for us on the OM market. It is definitely not going to be an empty field by the time we get there.
I'm also interested in what a GC4419 + B-OM combo would look like. Could be a future cocktail to really knock out OM in a big way.
GC4419 received breakthrough designation from the FDA. So it definitely works well. We will need phase 3 data on both drugs to know which works better.
Galera also raised money earlier this year for the phase 3 trials they will conduct. They will very likely succeed and be waiting for us on the OM market. It is definitely not going to be an empty field by the time we get there.
I'm also interested in what a GC4419 + B-OM combo would look like. Could be a future cocktail to really knock out OM in a big way.
(2)
(0)
